Wealthcare Advisory Partners’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,486
| Closed | -$219K | – | 890 |
|
|
2024
Q2 | $219K | Sell |
9,486
-386
| -4% | -$8.92K | 0.01% | 765 |
|
|
2024
Q1 | $238K | Sell |
9,872
-513
| -5% | -$12.4K | 0.01% | 732 |
|
|
2023
Q4 | $239K | Sell |
10,385
-774
| -7% | -$17.8K | 0.01% | 669 |
|
|
2023
Q3 | $227K | Sell |
11,159
-173,244
| -94% | -$3.53M | 0.01% | 621 |
|
|
2023
Q2 | $4.31M | Sell |
184,403
-41,283
| -18% | -$964K | 0.19% | 93 |
|
|
2023
Q1 | $5.25M | Buy |
225,686
+7,779
| +4% | +$181K | 0.23% | 82 |
|
|
2022
Q4 | $5.48M | Buy |
217,907
+42,040
| +24% | +$1.06M | 0.26% | 75 |
|
|
2022
Q3 | $4.64M | Sell |
175,867
-31,172
| -15% | -$823K | 0.26% | 78 |
|
|
2022
Q2 | $5.98M | Buy |
207,039
+41,358
| +25% | +$1.2M | 0.36% | 51 |
|
|
2022
Q1 | $5.71M | Buy |
165,681
+34,774
| +27% | +$1.2M | 0.35% | 45 |
|
|
2021
Q4 | $5.74M | Buy |
130,907
+10,833
| +9% | +$475K | 0.34% | 45 |
|
|
2021
Q3 | $6.09M | Buy |
120,074
+10,312
| +9% | +$523K | 0.4% | 41 |
|
|
2021
Q2 | $5.71M | Buy |
109,762
+20,494
| +23% | +$1.07M | 0.38% | 40 |
|
|
2021
Q1 | $4.08M | Buy |
89,268
+34,171
| +62% | +$1.56M | 0.3% | 46 |
|
|
2020
Q4 | $2.53M | Buy |
55,097
+30,427
| +123% | +$1.4M | 0.22% | 59 |
|
|
2020
Q3 | $961K | Buy |
+24,670
| New | +$961K | 0.11% | 124 |
|